Rb inhibits the intrinsic kinase activity of TATA-binding protein-associated factor TAFII250

J L Siegert1, P D Robbins

  • 1Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.

Insights

The retinoblastoma tumor suppressor protein (Rb) inhibits the kinase activity of TAFII250, a key transcription factor. This interaction, mediated by the Rb pocket, suggests a new way Rb regulates gene transcription.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Transcriptional Regulation

Background:

  • The retinoblastoma tumor suppressor protein (Rb) is crucial for cell cycle control.
  • TAFII250 is a large subunit of the TFIID complex, involved in transcription initiation.
  • Rb and TAFII250 interact, but the functional significance is unclear.

Purpose of the Study:

  • To investigate whether Rb regulates the kinase activity of TAFII250.
  • To elucidate the mechanism and functional domains involved in Rb-TAFII250 interaction.

Main Methods:

  • Immunopurification and gel purification of recombinant TAFII250.
  • In vitro kinase assays to measure TAFII250 autophosphorylation and RAP74 phosphorylation.
  • Site-directed mutagenesis of Rb to identify functional domains.

Main Results:

  • Rb inhibits the kinase activity of TAFII250 in a dose-dependent manner.
  • Rb's inhibitory function resides in its pocket domain (aa 379-928), not the N-terminus.
  • Rb specifically inhibits TAFII250's N-terminal kinase domain via direct interaction.
  • Rb pocket mutants (C706F, Deltaex22) are defective in kinase inhibition despite binding TAFII250.

Conclusions:

  • Rb directly inhibits TAFII250 kinase activity, suggesting a novel regulatory mechanism.
  • This inhibition involves specific interaction with TAFII250's kinase domain.
  • Rb's tumor suppressor function may involve modulating TAFII250's phosphorylation of itself and other targets like RAP74.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...